Pharma Journalist -

Eli Lilly and Company announced the successful completion of its acquisition of Versanis Bio. The acquisition expands Lilly's portfolio to include Versanis' lead asset, bimagrumab,…
Read More...

Novartis announced that it has completed its acquisition of Chinook Therapeutics, Inc., a Seattle, WA, based biopharmaceutical company focused on the discovery, development, and…
Read More...

Regeneron Pharmaceuticals, Inc. and Decibel Therapeutics, Inc., a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and…
Read More...

GenScript Biotech and T-MAXIMUM Biotech have formed a strategic collaboration agreement to enable the development of T-MAXIMUM's development CAR-T cell therapy using GenScript's CRISPR…
Read More...

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the company completed the expansion of its manufacturing space at…
Read More...

Celmatix Inc., a leading women’s health biotech focused on ovarian biology, and Aché Laboratórios, a leading Brazilian pharmaceutical company, today announced a collaboration and…
Read More...

GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has ramped up production of complex and modified peptides at its…
Read More...

Astex Pharmaceuticals (UK), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous…
Read More...

Ionis Pharmaceuticals, Inc. announced that it has entered a collaboration and license agreement with Novartis for the discovery, development and commercialization of a novel medicine…
Read More...

Kyverna Therapeutics, a clinical-stage cell therapy company with the mission of engineering a new class of therapies for autoimmune diseases, today announced the close of an…
Read More...